Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

Presentation AHA 2017

Clinical Benefit of Minimally-Interrupted Dabigatran versus Uninterrupted Warfarin for Catheter Ablation of Atrial Fibrillation: A Prospective Randomized Multicenter Trial

Presenter: Akihiko Nogami

November 13, 2017

Presentation CDM 2017

Current Approach of Atrial Fibrillation Management

Presenter: Wilber W. Su

October 06, 2017

Presentation LAA 2017

Pre-Procedural Imaging to Characterize the PFO: TTE, TEE, TCD

Presenter: Zahid Amin

July 22, 2017

Presentation LAA 2017

My 3 Most Challenging Transseptal Punctures in 5 Minutes

Presenter: Brian Whisenant

July 22, 2017

Presentation LAA 2017

Electrical/Ablation Approaches to AFib: Competitive or Complementary With LAA Closure?

Presenter: Vivek Y. Reddy

July 21, 2017

Presentation LAA 2017

Warfarin and NOACs in Non-Valvular Atrial Fibrillation

Presenter: Gregg W. Stone

July 21, 2017

Presentation LAA 2017

The Multifaceted Etiology of Stroke: Focus on Atrial Fibrillation and PFO

Presenter: M. Edip Gurol

July 21, 2017

Presentation

Prevalence, Management, and Long-term (6-Year) Outcomes of A-fib Among Patients Receiving DES

May 23, 2017

Presentation EuroPCR 2017

Routine Fractional Flow Reserve Measurement after Percutaneous Coronary Intervention The FFR-SEARCH Study

Presenter: Roberto Diletti

May 18, 2017

Presentation SCAI 2017

Results From The BRAVO 3 Randomized Trial

Presenter: Usman Baber

May 15, 2017

Presentation SWVS 2017

Atrial Fibrillation After SAVR: Optimizing management of peri-TAVR AF

Presenter: Ankur Kalra

May 06, 2017

Presentation SIF 2017

Thromboembolic Prophylaxis in Atrial Fibrillation

Presenter: Samir Kapadia

March 09, 2017

Presentation CRT 2017

Triple Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement

Presenter: Chadi Alraies

February 22, 2017

Presentation JIM 2017

Appendix Closure is the Solution

Presenter: Horst Sievert

February 10, 2017

Presentation

Apixaban in Patients With Atrial Fibrillation After TAVR

Presenter: J. Seeger

January 03, 2017

Advertisement

Clinical Benefit of Minimally-Interrupted Dabigatran versus Uninterrupted Warfarin for Catheter Ablation of Atrial Fibrillation: A Prospective Randomized Multicenter Trial

Current Approach of Atrial Fibrillation Management

Pre-Procedural Imaging to Characterize the PFO: TTE, TEE, TCD

My 3 Most Challenging Transseptal Punctures in 5 Minutes

Electrical/Ablation Approaches to AFib: Competitive or Complementary With LAA Closure?

Warfarin and NOACs in Non-Valvular Atrial Fibrillation

The Multifaceted Etiology of Stroke: Focus on Atrial Fibrillation and PFO

Prevalence, Management, and Long-term (6-Year) Outcomes of A-fib Among Patients Receiving DES

Routine Fractional Flow Reserve Measurement after Percutaneous Coronary Intervention The FFR-SEARCH Study

Results From The BRAVO 3 Randomized Trial

Atrial Fibrillation After SAVR: Optimizing management of peri-TAVR AF

Thromboembolic Prophylaxis in Atrial Fibrillation

Triple Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement

Appendix Closure is the Solution

Apixaban in Patients With Atrial Fibrillation After TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content